# Perioperative Combination Chemotherapy Versus Chemoradiation for Locally Advanced EGJ Adenocarcinoma

> **NCT03961841** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Sixth Affiliated Hospital, Sun Yat-sen University** · enrollment: 900 (estimated)

## Conditions studied

- Esophagogastric Junction Disorder
- Neoplasms

## Interventions

- **RADIATION:** chemoradiation with weekly 5Fu and oxaliplatin
- **DRUG:** Perioperative mFLOT
- **DRUG:** Perioperative FOLFOX

## Key facts

- **NCT ID:** NCT03961841
- **Lead sponsor:** Sixth Affiliated Hospital, Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2020-06
- **Primary completion:** 2024-08
- **Final completion:** 2029-08
- **Target enrollment:** 900 (ESTIMATED)
- **Last updated:** 2019-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03961841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03961841, "Perioperative Combination Chemotherapy Versus Chemoradiation for Locally Advanced EGJ Adenocarcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03961841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*